LAB Q1 2018 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

Q1 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$25M-1.1% YoY

Gross Profit

$13M53.2% margin

Operating Income

-$13M-50.0% margin

Net Income

-$13M-52.5% margin

EPS (Diluted)

$-0.34

QoQ Revenue Growth

-9.0%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$270M

Total Liabilities

$221M

Stockholders' Equity

$49M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$26M	-1.1%
Gross Profit	$13M	$14M	-1.0%
Operating Income	-$13M	-$18M	+28.0%
Net Income	-$13M	-$17M	+23.0%

Revenue Segments

Total Products

$20M45%

Consumables

$13M28%

Instruments

$8M16%

Services

$5M10%

Geographic Segments

UNITED STATES

$10M40%

Europe

$8M34%

Asia Pacific

$6M24%

Other Geographical Countries

$718,0003%